Double-Blind vs Control Group

Double-blind names two roles, not two people. The subjects do not know which treatment they received, and neither do the people who interact with them or score the response. The assignment has not vanished: it sits in a code held by someone who never meets a subject, and it is opened once the data are in. Blind exactly one of those two roles and the design is single-blind, whichever one it is. None of this describes what the control group receives.

A cold remedy trial randomly assigns 240 volunteers, 120 to the drug and 120 to an identical placebo, and the response is days until symptoms clear, judged by a nurse working from a checklist. Suppose the nurse knows the assignment and resolves borderline cases a quarter of a day early in the drug group and a quarter of a day late in the placebo group. The estimated difference between the groups then moves by $0.25 + 0.25 = 0.5$ days on its own, against a real drug effect of 0.8 days. Most of what got measured is the nurse. Coding the bottles so she cannot tell removes it and costs nothing.

The sentence to correct is "the study was double-blind because the control group got a placebo." A placebo is something the control group receives; blinding is about who knows. Identical pills from bottles marked A and B, with the nurse holding the key, is single-blind. A second version says the researchers must not know who got what. Somebody has to: the person who ran the randomization knows, and that is fine. The ones who must be kept in the dark are those in contact with subjects or scoring the outcome.

Plenty of experiments cannot be double-blind at all. A subject knows whether she spent twelve weeks lifting weights. Blinding whoever measures the outcome is still available, still worth doing, and still single-blind. Blinding protects a measurement and does nothing to balance the groups, so an unblinded randomized experiment still supports a causal claim while a blinded study without random assignment does not.

The control group is what the treatment group gets compared against, and its job is to be handled exactly like the treatment group in every respect except the one factor under test. What it actually receives depends on which comparison answers the question: nothing at all, an inactive placebo, or the treatment already in use. Units land in it through the same random mechanism that fills every other group, so it is not the pile of units left over.

A design with a control group and no placebo anywhere in it: 60 identical laptops, 30 randomly assigned new battery firmware and 30 keeping the shipping firmware, every machine running the same script at the same screen brightness in the same room. Mean runtime comes out 9.4 hours for the new firmware against 8.6 for the control, so the estimated effect is $9.4 - 8.6 = 0.8$ hours. No placebo is possible here and none is wanted, because a laptop has no expectations to manage. The control group is doing its entire job by supplying the 8.6.

Two sentences to stop writing. The first is "the control group is the group that gets nothing." Often it gets the current standard treatment instead, and where an effective treatment already exists, withholding it is both unethical and the wrong comparison, since the question is whether the new treatment beats the old one. The second is "the control group is what lets you claim cause and effect." Comparison alone does not do that. Random assignment is what makes the groups alike beforehand, and a control group compared against a self-selected treatment group establishes nothing.

Not every experiment has one. Comparing three doses of the same drug, or two teaching methods already in use, satisfies the comparison principle without a control group. An observational study is sometimes described as having one too, loosely: there the comparison group was never assigned, so the two groups can differ at the start in any number of ways.

Experimental design is topic 1.13 in Unit 1.